Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

All news

Show

From To
Hundreds of Pakistanis infected with HIV after doctor used contaminated dirty syringes

Pakistan was long considered a low prevalence country for HIV, but the disease is expanding at an alarming rate. The country currently has the second fastest growing HIV rates across Asia, according to the UN.

Published
16 May 2019
From
South China Morning Post
FDA's Breakthrough Designation Granted for Kaposi Sarcoma Therapy

Celgene’s pomalidomide (Pomalyst) has been granted Breakthrough Therapy designation by the FDA for the treatment of patients with previously-treated HIV-positive Kaposi sarcoma (KS) and patients with HIV-negative KS, according to a press release.

Published
15 May 2019
From
Pharmacy Times
Gilead tries—and fails—to dodge lawsuit claiming it delayed safer HIV meds

Gilead Sciences has faced years of allegations that it sidelined its safer, next-gen HIV drugs to reap as much revenue as possible from the older generation before the new meds hit. And a federal judge has allowed one set of those allegations—filed by 140 patients from 31 states—to proceed.

Published
15 May 2019
From
Fierce Pharma
Bolsonaro Cuts Harm Reduction, Escalates Drug War

Largely unreported in English-language news media, Brazilian President Jair Bolsonaro has pulled the plug on government support for harm reduction, instead calling for the promotion of abstinence and a crackdown on people who use and sell drugs.

Published
15 May 2019
From
Filter
New research finds heating drug use equipment linked to decreased HIV risk

Researchers found HIV was transmitted more through drug cookers than needles. Heating drug use equipment was found to reduce the risk of infection

Published
15 May 2019
From
CATIE
UCSD has not told women with HIV of data breach, despite researchers' pleas

University of California San Diego officials stonewalled attempts to notify women in an HIV research study that their confidential data was breached more than seven months ago, an inewsource investigation has found. UCSD researchers conducting the EmPower Women study told university officials in October that participants’ names, audio-taped conversations and other sensitive materials were made accessible to everyone working at Christie’s Place, a San Diego nonprofit supporting women with HIV and AIDS.

Published
15 May 2019
From
inewsource
Gilead struck anti-competitive deals to bolster profits on an HIV drug, lawsuit says

In a bid to maintain its dominance in the HIV market, Gilead Sciences (GILD) allegedly conspired with other drug makers whose medicines were part of a so-called combination cocktail in order to block generic competition, according to a lawsuit filed by AIDS activists and two unions.

Published
15 May 2019
From
STAT
Statement on Gilead’s Announcement of PrEP Donation

Gilead’s donation is an acknowledgment that there is a huge issue with PrEP access in America, as in many parts of the world. We welcome this indication that the company grasps the gravity of the situation. However, we urgently need a lower price for all. It’s disappointing that even this small step has taken so long.

Published
14 May 2019
From
AVAC
Case study: HIV campaign exceeds expectations and delivers life-changing results

A web TV series depicting the sex life of a young gay man is helping to protect others at risk of contracting HIV, as part of a successful campaign for 56 Dean Street, London's biggest NHS-run sexual health clinic.

Published
14 May 2019
From
PR Week
A Million Americans Need This Drug. Trump’s Deal Won’t Help Enough of Them.

A donation of H.I.V.-prevention drugs from the pharmaceutical giant Gilead could benefit shareholders more than patients.

Published
14 May 2019
From
The New York Times (editorial)

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.